Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-18-003093
Filing Date
2018-03-16
Accepted
2018-03-16 17:12:54
Documents
4
Effectiveness Date
2018-03-16

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs82018_actiniumpharma.htm S-8 89217
2 OPINION OF THE MATT LAW FIRM, PLLC fs82018ex5-1_actiniumpharma.htm EX-5.1 5557
3 CONSENT OF GBH CPAS, PC fs82018ex23-1_actiniumpharm.htm EX-23.1 1675
4 GRAPHIC image_001.jpg GRAPHIC 23679
  Complete submission text file 0001213900-18-003093.txt   130283
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-223741 | Film No.: 18696592
SIC: 2834 Pharmaceutical Preparations